HOME › DRUGS › LISOCABTAGENE MARALEUCEL
ACTIVE SUBSTANCE / INN

LISOCABTAGENE MARALEUCEL

Brand name(s): Breyanzi
EMA LISTED
AUTHORISED
Lymphoma, Large B-Cell, Diffuse;Lymphoma, Follicular;Mediast…
ACTIVE SUBSTANCE
Lisocabtagene Maraleucel
REGULATORS
EMA
SPONSORS / MAH
Bristol-Myers Squibb Pharma EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
BreyanziBristol-Myers Squibb Pharma EEIGAuthorised04/04/2022Lymphoma, Large B-Cell, Diffuse;Lymphoma, Follicular;Mediastinal Neoplasms

FULL INTELLIGENCE ON LISOCABTAGENE MARALEUCEL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →